Usefulness of Adaptive Complex Signal Average Diffusion-weighted MR Imaging of the Abdomen.

PURPOSE: To evaluate the clinical feasibility and quantitative performance of adaptive complex signal average (ACSA) diffusion-weighted imaging (DWI) in abdominal MRI and to compare ACSA DWI with conventional non-ACSA DWI in terms of signal intensity (SI), SNR, apparent diffusion coefficient (ADC), signal intensity difference ratio (SIDR), and lesion contrast across different numbers of excitations (NEX).

METHODS

This retrospective study included 82 patients who underwent free-breathing abdominal DWI on a 3T system between January and July 2025. ACSA DWI was reconstructed from the same raw data as non-ACSA DWI using a combination of adaptive averaging and complex-domain averaging. ROIs were placed in the liver, pancreas, left adrenal gland, and spinal muscles to measure SI, SNR, and ADC. SIDR and inter-lobar right-left (R-L) ratio in SI and ADC were calculated at NEX 2, 3, and 4. For 37 patients with non-cystic hepatic nodules, lesion SI, ADC, contrast ratio, and contrast-to-noise ratio (CNR) were assessed.

RESULTS

ACSA DWI significantly increased SI and SNR in motion-prone organs, including the lateral hepatic segment, pancreas, and left adrenal gland, at all NEX levels (P < 0.05). ADC values in abdominal parenchymal organs and hepatic nodules were lower with ACSA DWI, reflecting the noise-floor suppression and adaptive average effects. R-L SI and ADC ratios were significantly different and were closer to 1 in ACSA DWI, indicating improved hepatic signal homogeneity. Lesion SI, contrast ratio, and CNR were significantly higher with ACSA DWI, enhancing nodule conspicuity.

CONCLUSION

ACSA DWI improves signal uniformity, SNR, and lesion contrast while maintaining reasonable ADC quantification. Without prolonging scan time or modifying acquisition parameters, ACSA provides a robust, clinically feasible post-processing technique for enhancing both image quality and quantitative reliability in abdominal DWI.